Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 1/2024

22-10-2023 | Sarcoma | Thoracic Oncology

Impact of Surveillance Imaging in Detecting Local and Metastatic Lung Recurrences Among Patients with Sarcomas of the Extremities: A Systematic Review and Meta-analysis

Authors: Shyam Srinivasan, DM, Swaminathan Keerthivasagam, DM, Shathish Kumar, MD, Ajay Puri, MS

Published in: Annals of Surgical Oncology | Issue 1/2024

Login to get access

Abstract

Background

The surveillance guidelines following treatment completion for patients with high-grade sarcomas of the extremities are based largely upon expert opinions and consensus. In the current meta-analysis, we aim to study the utility of surveillance imaging to diagnose local and metastatic pulmonary relapses among patients with extremity soft tissue sarcomas and primary bone sarcomas.

Patients and Methods

A meta-analysis was performed to assess the sensitivity, specificity and diagnostic odds ratio (DOR) of surveillance imaging to diagnose local and metastatic pulmonary relapse among patients with sarcoma of the extremities. In addition, impact of surveillance imaging on overall survival was assessed. Heterogeneity among eligible studies was evaluated by I2 statistics. Sensitivity analysis was assessed using influence plots and Baujat plots.

Results

Ten studies including 2160 patients with sarcoma were found eligible. For diagnoses of local recurrence based on surveillance imaging (nine studies, 1917 patients), the estimated sensitivity, specificity, and DOR were 13.6%, 99.5%, and 78.15, respectively. Only 16.7% of local recurrences were diagnosed based on imaging. For diagnoses of metastatic pulmonary recurrence (eight studies; 1868 patients), estimated sensitivity, specificity, and DOR were 76.1%, 99.3%, and 1059.9, respectively. A sensitivity analysis showed significant heterogeneity among included studies. None of the included studies showed an overall-survival benefit with the use of surveillance imaging.

Conclusion

The current meta-analysis challenges the notion of routine use of imaging to detect local relapse, while favoring chest imaging, using either chest radiography or computed tomography scan, for surveillance. Further studies are required to study the ideal surveillance strategy including timing and imaging modality.
Appendix
Available only for authorised users
Literature
1.
2.
Clark MA, Fisher C, Judson I, Thomas JM. Soft-tissue sarcomas in adults. N Engl J Med. 2005;353(7):701–11.CrossRefPubMed
3.
Gamboa AC, Gronchi A, Cardona K. Soft-tissue sarcoma in adults: an update on the current state of histiotype-specific management in an era of personalized medicine. CA Cancer J Clin. 2020;70(3):200–29.CrossRefPubMed
4.
Potter DA, Glenn J, Kinsella T, Glatstein E, Lack EE, Restrepo C, et al. Patterns of recurrence in patients with high-grade soft-tissue sarcomas. J Clin Oncol. 1985;3(3):353–66.CrossRefPubMed
5.
Ferrari A, Alaggio R. Soft tissue sarcomas. CA Cancer J Clin. 2004;54:94–109.CrossRef
6.
Casali PG, Abecassis N, Bauer S, Biagini R, Bielack S, Bonvalot S, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv51-67.CrossRefPubMed
7.
8.
Gerrand CH, Billingham LJ, Woll PJ, Grimer RJ. Follow up after primary treatment of soft tissue sarcoma: a survey of current practice in the United Kingdom. Sarcoma. 2007;2007.
9.
Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PMM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56(11):1129–35.CrossRefPubMed
10.
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.CrossRefPubMed
11.
12.
Baujat B, Mahé C, Pignon JP, Hill C. A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials. Stat Med. 2002;21(18):2641–52.CrossRefPubMed
13.
Viechtbauer W, Cheung MW-L. Outlier and influence diagnostics for meta-analysis. Res Synth Methods. 2010;1(2):112–25.CrossRefPubMed
14.
Whooley BP, Gibbs JF, Mooney MM, McGrath BE, Kraybill WG. Primary extremity sarcoma: What is the appropriate follow-up? Ann Surg Oncol. 2000;7(1):9–14.CrossRefPubMed
15.
Cool P, Grimer R, Rees R. Surveillance in patients with sarcoma of the extremities. Eur J Surg Oncol. 2005;31(9):1020–4.CrossRefPubMed
16.
Labarre D, Aziza R, Filleron T, Delannes M, Delaunay F, Marques B, et al. Detection of local recurrences of limb soft tissue sarcomas: is magnetic resonance imaging (MRI) relevant? Eur J Radiol. 2009;72(1):50–3.CrossRefPubMed
17.
Cho HS, Park IH, Jeong WJ, Han I, Kim HS. Prognostic value of computed tomography for monitoring pulmonary metastases in soft tissue sarcoma patients after surgical management: A retrospective cohort study. Ann Surg Oncol. 2011;18(12):3392–8.CrossRefPubMed
18.
Chou YS, Liu CY, Chen WM, Chen TH, Chen PCH, Wu HTH, et al. Follow-up after primary treatment of soft tissue sarcoma of extremities: Impact of frequency of follow-up imaging on disease-specific survival. J Surg Oncol. 2012;106(2):155–61.CrossRefPubMed
19.
Cheney MD, Giraud C, Goldberg SI, Rosenthal DI, Hornicek FJ, Choy E, et al. MRI surveillance following treatment of extremity soft tissue sarcoma. J Surg Oncol. 2014;109(6):593–6.CrossRefPubMed
20.
Rothermundt C, Whelan JS, Dileo P, Strauss SJ, Coleman J, Briggs TW, et al. What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients. Br J Cancer. 2014;110(10):2420–6.CrossRefPubMedPubMedCentral
21.
Puri A, Gulia A, Hawaldar R, Ranganathan P, Badwe RA. Does intensity of surveillance affect survival after surgery for sarcomas? Results of a randomized noninferiority trial. Clin Orthop Relat Res. 2014;472(5):1568–75.CrossRefPubMed
22.
Rothermundt C, Seddon BM, Dileo P, Strauss SJ, Coleman J, Briggs TW, et al. Follow-up practices for high-grade extremity osteosarcoma. BMC Cancer. 2016;16(1):1–6.CrossRef
23.
Cool P, Cribb G. The impact and efficacy of surveillance in patients with sarcoma of the extremities. Bone Jt Res. 2017;6(4):224–30.CrossRef
24.
25.
Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, et al. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up☆. Ann Oncol. 2021;32(11):1348–65.CrossRefPubMed
26.
Gamboa AC, Ethun CG, Switchenko JM, Lipscomb J, Poultsides GA, Grignol V, et al. Lung surveillance strategy for high-grade soft tissue sarcomas: chest x-ray or CT scan? J Am Coll Surg. 2019;229(5):449.CrossRefPubMedPubMedCentral
27.
Thompson CA, Charlson ME, Schenkein E, Wells MT, Furman RR, Elstrom R, et al. Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors. Ann Oncol. 2010;21(11):2262–6.CrossRefPubMedPubMedCentral
28.
Cash T, Bettermann EL, Mitchell S, McCracken C, Qayed M, Wolfe D, et al. Routine Surveillance imaging is associated with improved postrelapse survival in patients with ewing sarcoma. J Adolesc Young Adult Oncol. 2020;9(3):394–401.CrossRefPubMed
29.
Zhou GQ, Wu CF, Deng B, Gao TS, Lv JW, Lin L, et al. An optimal posttreatment surveillance strategy for cancer survivors based on an individualized risk-based approach. Nat Commun. 2020;11(1):1–9.
30.
Miller BJ, CarmodySoni EE, Reith JD, Gibbs CP, Scarborough MT. CT scans for pulmonary surveillance may be overused in lower-grade sarcoma. Iowa Orthop J. 2012;32:28–34.PubMedPubMedCentral
31.
Goel A, Christy MEL, Virgo KS, Kraybill WG, Johnson FE. Costs of follow-up after potentially curative treatment for extremity soft-tissue sarcoma. Int J Oncol. 2004;25(2):429–35.PubMed
32.
Cahlon O, Brennan MF, Jia X, Qin LX, Singer S, Alektiar KM. A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation. Ann Surg. 2012;255(2):343–7.CrossRefPubMed
33.
Callegaro D, Miceli R, Bonvalot S, Ferguson P, Strauss DC, Levy A, et al. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. Lancet Oncol. 2016;17(5):671–80.CrossRefPubMed
34.
Liu S, Sun W, Yang S, Duan L, Huang C, Xu J, et al. Deep learning radiomic nomogram to predict recurrence in soft tissue sarcoma: a multi-institutional study. Eur Radiol. 2022;32(2):793–805.CrossRefPubMed
35.
Sun BJ, Li A, Alobuia W, et al. Detection of circulating tumor DNA predicts recurrence in soft tissue sarcomas. 2023 Society of Surgical Oncology International Conference on Surgical Cancer Care. Abstract 78. JCO Precis Oncol. March 22, 2023. In.
Metadata
Title
Impact of Surveillance Imaging in Detecting Local and Metastatic Lung Recurrences Among Patients with Sarcomas of the Extremities: A Systematic Review and Meta-analysis
Authors
Shyam Srinivasan, DM
Swaminathan Keerthivasagam, DM
Shathish Kumar, MD
Ajay Puri, MS
Publication date
22-10-2023
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 1/2024
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-023-14429-9

Other articles of this Issue 1/2024

Annals of Surgical Oncology 1/2024 Go to the issue

Breast Oncology

Surgical Decision Making in Genetically High-Risk Women: Quantifying Postoperative Complications and Long-Term Risks of Supplemental Surgery After Risk-Reducing Mastectomy

ASO Author Reflections

ASO Author Reflections: A Novel, Sensitive, and Effective Index in Predicting Therapeutic Response of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma

Hepatobiliary Tumors

Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis

ASO Perspectives

Neoadjuvant and Adjuvant Pembrolizumab for the Treatment of Early-Stage Resectable Non-small Cell Lung Cancer An Editorial Regarding the Interim Data Analysis of the KEYNOTE-671 Phase III Trial of Neoadjuvant and Adjuvant Pembrolizumab

ASO Author Reflections

ASO Author Reflections: Tumor Necrosis—A Poor Prognostic Factor of Gallbladder Carcinoma

ASO Author Reflections

ASO Author Reflections: Preoperative Assessment of Nodal Burden in Breast Cancer